18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis

被引:30
作者
Laudicella, Riccardo [1 ]
Albano, Domenico [2 ]
Alongi, Pierpaolo [3 ]
Argiroffi, Giovanni [4 ]
Bauckneht, Matteo [5 ]
Baldari, Sergio [1 ]
Bertagna, Francesco [2 ]
Boero, Michele [6 ]
De Vincentis, Giuseppe [7 ]
Del Sole, Angelo [4 ]
Rubini, Giuseppe [8 ]
Fantechi, Lorenzo [9 ]
Frantellizzi, Viviana [10 ]
Ganduscio, Gloria [3 ]
Guglielmo, Priscilla [6 ]
Nappi, Anna Giulia [8 ]
Evangelista, Laura [11 ]
机构
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Nucl Med Unit, I-98125 Messina, Italy
[2] Univ Brescia & Spedali Civili Brescia, Dept Nucl Med, I-25123 Brescia, Italy
[3] Fdn Ist G Giglio, Unit Nucl Med, I-90015 Cefalu, Italy
[4] Univ Milan, Dept Hlth Sci, I-20142 Milan, Italy
[5] IRCCS Policlin San Martino, Nucl Med Unit, I-16132 Genoa, Italy
[6] AO Brotzu, Nucl Med Unit, I-09134 Cagliari, Italy
[7] Sapienza Univ Rome, Dept Radiol Sci Oncol & Anat Pathol, I-00161 Rome, Italy
[8] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Nucl Med Unit, I-70124 Bari, Italy
[9] Univ Pisa, Nucl Med Unit, Dept New Technol & Translat Res Med & Surg, I-56126 Pisa, Italy
[10] Sapienza Univ Rome, Dept Mol Med, I-00185 Rome, Italy
[11] Veneto Inst Oncol IOV IRCCS, Nucl Med Unit, I-35128 Padua, Italy
关键词
prostate cancer; F-18-FACBC; PET/CT; recurrence; meta-analysis; review; ANTI-1-AMINO-3-F-18-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; MULTIPARAMETRIC MRI; PET/CT; PERFORMANCE; TOMOGRAPHY; EXPERIENCE; CARCINOMA; DIAGNOSIS;
D O I
10.3390/cancers11091348
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Trans-1-amino-3-F-18-fluorocyclobutanecarboxylic-acid (anti-[F-18]-FACBC) has been approved for the detection of prostate cancer (PCa) in patients with elevated prostate-specific-antigen following prior treatment. This review and meta-analysis aimed to investigate the diagnostic performance of F-18-FACBC positron emission tomography/computed-tomography (PET/CT) in the detection of primary/recurrent PCa. A bibliographic search was performed including several databases, using the following terms: "FACBC"/"fluciclovine" AND "prostate cancer"/"prostate" AND "PET"/"Positron Emission Tomography". Fifteen and 9 studies were included in the systematic reviews and meta-analysis, respectively. At patient-based analysis, the pooled sensitivity and specificity of F-18-FACBC-PET/CT for the assessment of PCa were 86.3% and 75.9%, respectively. The pooled diagnostic odds-ratio value was 16.453, with heterogeneity of 30%. At the regional-based-analysis, the pooled sensitivity of F-18-FACBC-PET/CT for the evaluation of primary/recurrent disease in the prostatic bed was higher than in the extra-prostatic regions (90.4% vs. 76.5%, respectively); conversely, the pooled specificity was higher for the evaluation of extra-prostatic region than the prostatic bed (89% vs. 45%, respectively). F-18-FACBC-PET/CT seems to be promising in recurrent PCa, particularly for the evaluation of the prostatic bed. Additional studies to evaluate its utility in clinical routine are mandatory.
引用
收藏
页数:17
相关论文
共 42 条
[1]   Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images [J].
Abd-Alazeez, M. ;
Ramachandran, N. ;
Dikaios, N. ;
Ahmed, H. U. ;
Emberton, M. ;
Kirkham, A. ;
Arya, M. ;
Taylor, S. ;
Halligan, S. ;
Punwani, S. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (02) :128-136
[2]   Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study [J].
Ahmed, Hashim U. ;
Bosaily, Ahmed El-Shater ;
Brown, Louise C. ;
Gabe, Rhian ;
Kaplan, Richard ;
Parmar, Mahesh K. ;
Collaco-Moraes, Yolanda ;
Ward, Katie ;
Hindley, Richard G. ;
Freeman, Alex ;
Kirkham, Alex P. ;
Oldroyd, Robert ;
Parker, Chris ;
Emberton, Mark .
LANCET, 2017, 389 (10071) :815-822
[3]   Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients [J].
Akin-Akintayo, Oladunni ;
Tade, Funmilayo ;
Mittal, Pardeep ;
Moreno, Courtney ;
Nieh, Peter T. ;
Rossi, Peter ;
Patil, Dattatraya ;
Halkar, Raghuveer ;
Fei, Baowei ;
Master, Viraj ;
Jani, Ashesh B. ;
Kitajima, Hiroumi ;
Osunkoya, Adeboye O. ;
Ormenisan-Gherasim, Claudia ;
Goodman, Mark M. ;
Schuster, David M. .
EUROPEAN JOURNAL OF RADIOLOGY, 2018, 102 :1-8
[4]   Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer [J].
Akin-Akintayo, Oladunni O. ;
Jani, Ashesh B. ;
Odewole, Oluwaseun ;
Tade, Funmilayo I. ;
Nieh, Peter T. ;
Master, Viraj A. ;
Bellamy, Leah M. ;
Halkar, Raghuveer K. ;
Zhang, Chao ;
Chen, Zhengjia ;
Goodman, Mark M. ;
Schuster, David M. .
CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) :E22-E28
[5]   The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial [J].
Andriole, Gerald L. ;
Kostakoglu, Lale ;
Chau, Albert ;
Duan, Fenghai ;
Mahmood, Umar ;
Mankoff, David A. ;
Schuster, David M. ;
Siegel, Barry A. ;
Adler, Lee P. ;
Belkoff, Laurence H. ;
Burzon, Daniel ;
Dato, Paul ;
Farwell, Michael ;
Fogelson, Stephen ;
Gardiner, Peter ;
Hanna, Lucy ;
Hoffman, John M. ;
Intenzo, Charles ;
Josephson, David ;
Kaminetsky, Jed ;
Kipper, Michael ;
Krynyckyi, Borys ;
Linder, Karen E. ;
Marques, Helga ;
Melnick, John ;
Miller, Matthew P. ;
Oh, William ;
Philips, Shaile ;
Rose, Judith ;
Savir-Baruch, Bital ;
Stevens, Daniel J. ;
Tewari, Ashutosh ;
Twardowski, Przemyslaw ;
Ward, Penelope ;
Wasserman, Martha ;
Weick, Sharon ;
Yu, Jian Q. .
JOURNAL OF UROLOGY, 2019, 201 (02) :322-330
[6]   Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer [J].
Bach-Gansmo, Tore ;
Nanni, Cristina ;
Nieh, Peter T. ;
Zanoni, Lucia ;
Bogsrud, Tronde Velde ;
Sletten, Heidi ;
Korsan, Katrine Andersen ;
Kieboom, J. ;
Tade, Funmilayo I. ;
Odewole, Oluwaseun ;
Chau, Albert ;
Ward, Penelope ;
Goodman, Mark M. ;
Fanti, Stefano ;
Schuster, David M. ;
Willoch, Frode .
JOURNAL OF UROLOGY, 2017, 197 (03) :676-682
[7]  
Bruce Justine Yang, 2012, Clin Adv Hematol Oncol, V10, P716
[8]   18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial [J].
Calais, Jeremie ;
Ceci, Francesco ;
Eiber, Matthias ;
Hope, Thomas A. ;
Hofman, Michael S. ;
Rischpler, Christoph ;
Bach-Gansmo, Tore ;
Nanni, Cristina ;
Savir-Baruch, Bital ;
Elashoff, David ;
Grogan, Tristan ;
Dahlbom, Magnus ;
Slavik, Roger ;
Gartmann, Jeannine ;
Nguyen, Kathleen ;
Lok, Vincent ;
Jadvar, Hossein ;
Kishan, Amar U. ;
Rettig, Matthew B. ;
Reiter, Robert E. ;
Fendler, Wolfgang P. ;
Czernin, Johannes .
LANCET ONCOLOGY, 2019, 20 (09) :1286-1294
[9]   18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment [J].
England, Joseph R. ;
Paluch, Jeremy ;
Ballas, Leslie K. ;
Jadvar, Hossein .
CLINICAL NUCLEAR MEDICINE, 2019, 44 (03) :e128-e132
[10]   Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis [J].
Evangelista, Laura ;
Guttilla, Andrea ;
Zattoni, Fabio ;
Muzzio, Pier Carlo ;
Zattoni, Filiberto .
EUROPEAN UROLOGY, 2013, 63 (06) :1040-1048